The effect of gut microbiota on the response to neoadjuvant DCF therapy for locally advanced esophageal cancer: A single center prospective study
Not Applicable
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000035732
- Lead Sponsor
- Department of gastrointestinal Surgery, Graduate School of Medicine, The university of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1)unable to join due to his/her mental status or metal disorder (2)attending doctors judge him/her to be inappropriate to join in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the transition of the microbiota of the patients during neoadjuvant chemotherapy.(before chemotherapy and after chemotherapy)
- Secondary Outcome Measures
Name Time Method a. the difference of microbiota between patients who responded well to chemotherapy and patients who did not respond. b.the difference of microbiota between patients who sufferd adverse effects and patients who did not suffer them.